The UK Medicines and Healthcare products Regulatory Agency (MHRA) has made updated safety and educational materials available. These resources are intended to help implement the regulatory measures outlined in the November 2023 National Patient Safety Alert and the September 2024 Drug Safety Update.
The new materials aim to support healthcare professionals in discussing relevant risks with patients, ensuring compliance with the latest safety guidance.
Regulatorische Updates24. Aug. 2026•1 Min. Lesezeit
MHRA Publishes Updated Safety and Educational Materials
MHRA releases new safety and educational resources to support regulatory measures from the 2023 Patient Safety Alert and 2024 Drug Safety Update.
Zusammengestellt vom PharmaCountry-Team · Quelle: MHRA
Bewertungen
(0)
(0)
(0)
(0)
(0)
Weitere Artikel
Alle Einblicke anzeigenStudien & Berichte
Global Finished Dosage Manufacturing Landscape 2026
5. Okt. 2026
Regulatorische UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
28. Sept. 2026
AnalysePharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
28. Sept. 2026
Bewertung hinterlassen